Wed, Sep 11, 2024
Which stocks including Aarti Drugs, Ixigo, General Insurance and Jubilant Pharmova will be in focus today?, On the basis of which news there will be action in the market?, What are the important triggers for the market? Know here in Stock In News.
More >
Wed, May 08, 2024
Share market opened in red on Wednesday, May 8, 2024. While Nifty slid below the 22,250, BSE Sensex was down by more than 200 points. The market also closed in negative a day ago.
Mon, May 06, 2024
Margin improvement possible further: Adheesh Patil, CFO, Aarti Drugs, talks with top management of Aarti Drugs on results and sector outlook
Fri, Oct 20, 2023
FIRST ON ZEE BUSINESS- Exports demand slightly less, expected further improvement: Adheesh Patil, CFO, Aarti Drugs
Mon, Jul 24, 2023
Good performance in domestic business... Margin expected to be 15% going forward: Adhish Patil, CFO, Aarti Drugs
Aarti Drugs' borad has set the buyback price at Rs 900 per equity share.
Wed, Aug 17, 2022
According to a Zee Business report, the Directorate General of Trade Remedies (DGTR) under the Ministry of Commerce and Industry has proposed to impose a levy of $0.53 to $7 per kg for the next 5 years on Ofloxacin and intermediates imported from China.
Recommendation of duty on ofloxacin and intermediates imported from China. Anti-dumping proposal from $0.53 to $7/kg for the year. DGTR completed investigation on the application of Aarti drugs. Know full news from Ambarish Pandey. Know full news from Ambareesh Pandey ...
Tue, May 10, 2022
How were the results of Aarti Drugs in Q4? What were the reasons for falling profits, margins? What were the key triggers for the results? What is the growth outlook going forward? Watch Anil Singhvi's exclusive conversation with Adhish Patil, CFO, Aarti Drugs.
Fri, Mar 12, 2021
Breaking News With Anil Singhvi: Zee Business correspondent Chetan Bhutani has said that the Government of India has issued a final notification on one drug which is used to cure many infections. The drug is called Ciprofloxacin Hydrochloride. Now official notification has been imposed on Ciprofloxacin Hydrochloride for 5 years and an official announcement has been made related to this decision.
Fri, Jan 29, 2021
Aarti Drugs Q3 FY21 margins surpassed our expectation. Its EBITDA margin expanded 569 bps to 19.9%, driven by better realisations in APIs and import-duty imposition on key products such as ciprofloxacin. Sales grew 12% to Rs 5.3 bn. The API division contributed 87% to sales and grew 13.1% to Rs.4.6bn. Formulations sales were up 5.2% to Rs 697 mn.
Fri, Aug 21, 2020
Today in 'News Par Views' know with Chief Financial Officer (CFO) Adhish Patel, what is the future planning of Aarti Drugs Limited?
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
